ChanGes In Right ventricular volumes And Function Following diurEtic Treatment In Pulmonary arterial hypertension patients with decompensated right heart failure (GIRAFFE)
- Conditions
- pulmonary hypertensionright heart failure1008220610037454
- Registration Number
- NL-OMON44204
- Lead Sponsor
- Vrije Universiteit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 34
- Diagnosis of idiopathic PAH, hereditary PAH, drug- and toxins induced PAH or chronic thrombo-embolic PH (CTEPH), according to ESC/ERS pulmonary hypertension guidelines (15)
- Symptoms of decompensated right heart failure (ankle edema, ascites, weight gain) based on the assessment and the evaluation of the pulmonologist for which an up-titration of the diuretics is indicated
- Age >=18 and <=80 years
- Able to understand and willing to sign the Informed Consent Form
- Pregnant subjects
- Claustrophobia
- Inability to provide informed consent
- Change in PAH specific therapy during or the 3 months before the up-titration of diuretics
- Change in (dose) of any other medication.
- One or more of the following co-morbidities:, uncontrolled systemic hypertension (>140/90 mmHg) , renal failure (eGFR <30), recent diagnosis of pulmonary embolism (within 6 months).
- Contraindication for CMR imaging:
o Claustrophobia
o Implanted cardiac defibrillator or pacemaker
o Cochlear implant
o Others
- PH of any cause other than permitted in the entry criteria
- Known history of noncompliance considering therapies
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Change in stroke volume (SV) , Change in right ventricular ejection fraction<br /><br>(RVEF) (%), Change in right ventricular end diastolic volume (RVEDV) (ml),<br /><br>Change in right ventricular end systolic volume (RVESV) (ml), Change in right<br /><br>atrial pressure (RAP),volume, Change in right ventricular strain.</p><br>
- Secondary Outcome Measures
Name Time Method <p>nvt</p><br>